mesowatch
Protein Reactivation Offers Insights
Section divider

Protein Reactivation Offers Insights into Mesothelioma Origins

lab workers testing proteins

Researchers at the University of Colorado Anschutz Medical Campus, alongside international collaborators, have made a significant discovery regarding the origin of mesothelioma, an aggressive cancer.

They found that a protein crucial in embryonic development, Hand2, is reactivated in certain mesothelioma cases, shedding light on the mechanisms driving this deadly disease.

The study, published in Nature Communications, marks a crucial step in understanding mesothelioma’s complex pathogenesis.

Unveiling the Role of Hand2

Lead author Christian Mosimann, PhD, associate professor of pediatrics at the University of Colorado School of Medicine, explains that Hand2, a protein involved in early cellular development, is dormant in most tissues after embryonic development.

However, in numerous mesothelioma tumors, Hand2 becomes reactivated, potentially altering tumor cell behavior. This discovery presents an opportunity to explore Hand2’s role in mesothelioma progression and develop targeted therapies.

Mesothelioma is an aggressive cancer affecting the mesothelium, a thin tissue layer covering internal organs. Typically caused by asbestos exposure, mesothelioma remains a formidable medical challenge due to its elusive nature and poor prognosis.

Mosimann’s team utilizes zebrafish as a model organism to investigate cellular development, leveraging their translucent nature to observe developmental processes. By studying mesothelium formation in zebrafish embryos, the researchers uncovered Hand2’s pivotal role in the initial development of this tissue.

The reactivation of Hand2 in mesothelioma tumors offers a potential therapeutic target. By elucidating the mechanisms behind Hand2 activation and its impact on tumor growth and metastasis, researchers aim to develop novel treatments to combat this deadly disease.

Addressing Global Health Concerns

Asbestos exposure remains a global health concern, with mesothelioma cases arising decades after initial exposure. The continued use of asbestos in construction and mining industries underscores the urgency of finding effective treatments for mesothelioma.

Mosimann’s team will investigate strategies to manipulate Hand2 activity in mesothelioma cells, aiming to develop targeted therapies with minimal off-target effects. Additionally, they will explore why Hand2 reactivation occurs in specific mesothelioma cases, unraveling further insights into the disease’s heterogeneity.

Beyond mesothelioma research, the team’s work holds promise for understanding congenital conditions involving the mesothelium. Insights gained from zebrafish studies may pave the way for improved diagnosis and treatment of congenital anomalies affecting this vital tissue.

The discovery of Hand2 reactivation in mesothelioma tumors represents a significant advancement in cancer research. By unraveling the molecular mechanisms driving mesothelioma progression, researchers aim to pave the way for more effective treatments and better outcomes for patients battling this aggressive cancer.

Amna Anees

Reading Time: 1 mins

Published On: March 30, 2022

Amna Anees - author

Amna is a molecular biologist and has a deep interest in the field of health and medicine. She has worked in the field of proteomics and plants molecular biology. Being a biologist herself, she has developed an interest in the field of therapeutic studies of mesothelioma and related researches.

More to Read

Section Divider

John Edwards - September 24, 2024

Arizona Veterans: The Persistent Danger of Asbestos Exposure

Mini Divider

News & Data

News & Data Divider
Hands of a veteran in military uniform, clasped together in reflection.

Arizona Veterans: The Persistent Danger of Asbestos Exposure

By John Edwards

Read Story
j&j talcum powder bottle, contains asbestos

Johnson & Johnson Faces Critical Legal Test in Connecticut

By Matthew Davis

Read Story
chemotherapy is next frontier for mesothelioma treatment

FDA Approves Pembrolizumab with Chemotherapy for Advanced Mesothelioma

By Amna Anees

Read Story
https://www.istockphoto.com/photo/scales-of-justice-and-gavel-on-wooden-table-and-lawyer-or-judge-working-with-gm939262058-256820558

Asbestos Litigation Trends Reveal Ongoing Health Crisis, Study Finds

By Jared Reagan

Read Story
mesothelioma jury verdict

J&J Subsidiary Declares Bankruptcy to Push Forward $10 Billion Talc Settlement

By Rachel Sasser

Read Story
mark leniar trial lawyer secures 39m - lady justice texas flag

$39M Awarded In Mesothelioma Case Tied to Medical Contaminated Talc

By Rachel Sasser

Read Story
Featured Image

Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase

By Matthew Davis

Read Story
Lady Justice And Columns Of A Courthouse Facade

J&J Raises Talcum Powder Settlement by Another $1.1 Billion

By Matthew Davis

Read Story
Mini Divider
mesowatch

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy Policy

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
The content on this website is protected by law and provided for informational purposes only. It is not intended as a substitute for professional medical or legal advice. Always seek advice from qualified professionals for health or legal matters.Disclaimer